• Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Identification of a primary target of thalidomide teratogenicity.

Half a century ago, thalidomide was widely prescribed to pregnant women as a sedative but was found to be teratogenic, causing multiple birth defects. Today, thalidomide is still used in the treatment of leprosy and multiple myeloma, although how it causes limb malformation and other developmental defects is unknown. Here, we identified cereblon (CRBN) as a thalidomide-binding protein. CRBN forms an E3 ubiquitin ligase complex with damaged DNA binding protein 1 (DDB1) and Cul4A that is important for limb outgrowth and expression of the fibroblast growth factor Fgf8 in zebrafish and chicks. Thalidomide initiates its teratogenic effects by binding to CRBN and inhibiting the associated ubiquitin ligase activity. This study reveals a basis for thalidomide teratogenicity and may contribute to the development of new thalidomide derivatives without teratogenic activity.

Pubmed ID: 20223979

Authors

  • Ito T
  • Ando H
  • Suzuki T
  • Ogura T
  • Hotta K
  • Imamura Y
  • Yamaguchi Y
  • Handa H

Journal

Science (New York, N.Y.)

Publication Data

March 12, 2010

Associated Grants

None

Mesh Terms

  • Animals
  • Carrier Proteins
  • Chick Embryo
  • Cullin Proteins
  • DNA-Binding Proteins
  • Embryo, Nonmammalian
  • Embryonic Development
  • Fibroblast Growth Factors
  • Forelimb
  • Gene Expression Regulation, Developmental
  • HeLa Cells
  • Humans
  • Mutant Proteins
  • Peptide Hydrolases
  • Teratogens
  • Thalidomide
  • Ubiquitin-Protein Ligases
  • Ubiquitination
  • Zebrafish
  • Zebrafish Proteins